Evidence map›Paper›PMID 34996766›Full record

ArticleBMJ global health2022

Ethical health security in the age of antimicrobial resistance.

Kari Pahlman, Anson Fehross, Greg J Fox, Diego S Silva

Abstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. More Carrots, Less Sticks: Encouraging Good Stewardship in the Global Antimicrobial Commons.Health care analysis : HCA : journal of health philosophy and policy · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kari PahlmanSydney Health Ethics, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-1259-5120
Anson FehrossSydney Health Ethics, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Greg J FoxCentral Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Diego S SilvaSydney Health Ethics, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia diego.silva@sydney.edu.au diego.silva@sydney.edu.au.ORCID 0000-0002-8195-6404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOwing to its potential human, social and economic costs, antimicrobial resistance (AMR) is frequently referred to as a threat to health security. Simultaneously, health security and the preservation of antimicrobials are often described as a global public good. However, how the term 'public good' is used in the context of health security, and the values that underpin it, remains ambiguous. Policymaking is never value-free, and a better examination of such values is critical to understanding how issues such as AMR are problematised and how policy decisions are informed.

designWe used McDougall's version of critical interpretive synthesis to capture the recurring concepts and arguments within public policy, political science and applied ethics literature on AMR. Articles were analysed by identifying recurring ideas and developing themes across the literature.

resultsA total of 77 papers were included in our review. In the context of health security and AMR, the concept of 'public good' appears to be used interchangeably with 'common good', reflecting confusion, but sometimes meaningful differences, regarding how antimicrobials, as a good, are conceived. Main approaches to addressing AMR are statism, globalism and regionalism, which appeal to different values in guiding policymakers. Common justificatory values underpinning preservation of antimicrobials as a public good were prevention of harm, solidarity, justice and rights.

conclusionThe findings suggest that within the literature there is a lack of conceptual clarity as to whether antimicrobials constitute a public good or a common good. Moreover, the way in which antimicrobials are conceived and the approaches through which AMR as a threat to health security is addressed appear to be grounded in values that are often implicit. Being explicit about the values that underpin AMR and health security is not simply an intellectual exercise but has very real policy and programmatic implications.

Indexed as

Anti-Infective AgentsDrug Resistance, BacterialAnti-Bacterial AgentsHumansPolicyPolicy MakingAnti-Bacterial AgentsAnti-Infective Agentsdiseasesdisordershealth policyinfectionsinjuriesprevention strategiespublic healthreview

Identifiers

PMID34996766
PMCPMC8743836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.